MDT Comments on Academy of General Dentistry’s Choice of Cosmetic Procedures over Gum Disease Treatment
Read more: http://www.financialpost.com/markets/news/Comments+Academy+General+Dentistry+Choice+Cosmetic+Procedures+over+Disease+Treatment/3258867/story.html#ixzz0tFPGQCzF
The dentists who form Millennium Dental Technologies, Inc. (MDT), and are pioneers of the patented LANAP™ protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser, today released a statement questioning the Academy of General Dentistry’s (AGD) priorities. The AGD has given Botox® seminars center stage at their annual meeting in New Orleans July 8-11, with heavy promotion of the cosmetic procedure workshops in a focused e-mail marketing campaign and headlines in its recent e-newsletter.
Delwin K. McCarthy, DDS , MDT Co-Founder and AGD member comments that, “it is a strange choice of priorities for a dental healthcare organization when 85% of adult Americans suffer from gum disease—a life threatening and always treatable infection increasingly associated with various systemic conditions.”
Periodontal disease —also known as gum disease gum disease—is a silent, painless, chronic, communicable, bacterial infection that often goes undetected or ignored until there are severe dental consequences such as infections, abscesses and tooth loss. Recently, periodontal disease bacteria has been scientifically confirmed in the death of a stillborn baby. Organized dentistry’s failure to confront this death as well as AGD’s emphasis on Botox® is evidence of a disconnect between “need- and want-based” health care treatment emphasis.
“Given that each year more than 100 million Americans go without treatment for periodontal disease —a condition known to be linked to several life-threatening adult diseases and even preterm or stillbirth of newborns—I fail to understand how the AGD can justify its emphasis on Botox®,” states Dr. Robert H. Gregg, DDS, MDT Co-Founder and AGD member.
MDT Vice President and Board Member, Dawn Bloore DDS, also an AGD member, comments: “Dentistry is about treating patients and defeating their diseases, not about superficial cosmetic procedures that have transient sex appeal.”
Seeking to bridge the growing divide between gum disease gum disease patients and dentists/periodontists, MDT offers the FDA-cleared and patented LANAP LANAP™ protocol—a no cut, no sew, no fear solution to gum disease that utilizes a tiny laser fiber (about the thickness of three human hairs) to clear away infection without cutting the gums. This industry-shaking medical advancement results in scientifically proven regenerative outcomes, offering less post-operative pain and fewer treatments, with faster recovery and lasting results.
ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc. is the developer of the LANAP LANAP™ protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared and patentedLANAP LANAP protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional scalpel/suture flap surgery conventional scalpel/suture flap surgery; its PerioLase® MVP-7™ is a 6-watt free-running variable pulsed Nd:YAG dental laser featuring digital technology and 7 pulse durations—the most available on the market—giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. Established in 1990, the company’s founding clinicians, Robert H. Gregg, II, D.D.S. and Delwin K. McCarthy, D.D.S., continue to operate the company with a shared vision and purpose: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—“It’s all about the patient.”